Opinion

Video

Impact of Treatment Delays on Patient Outcomes

Key Takeaways

  • Timely intervention in oncology is critical for improving survival rates, disease progression, and quality of life.
  • Delays in treatment can result in advanced disease stages, reduced treatment efficacy, and increased morbidity.
SHOW MORE

Toby Maher, MD, PhD, discusses how delays in treatment for idiopathic pulmonary fibrosis (IPF) can significantly worsen patient outcomes and accelerate disease progression, underscoring the critical need for timely intervention.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Gordon Crofoot, MD, PA
Dr Brian Slomovitz
4 experts are featured in this series.
2 experts in this video
2 experts in this video
4 experts are featured in this series.
1 expert in this video
5 experts are featured in this series
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo